341 related articles for article (PubMed ID: 20460397)
1. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
Bazaz R; Chapman AL; Winstanley TG
J Antimicrob Chemother; 2010 Jul; 65(7):1510-3. PubMed ID: 20460397
[TBL] [Abstract][Full Text] [Related]
2. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Dalgic N; Sancar M; Bayraktar B; Dincer E; Pelit S
Scand J Infect Dis; 2011 May; 43(5):339-43. PubMed ID: 21271945
[TBL] [Abstract][Full Text] [Related]
3. Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
Teng CP; Chen HH; Chan J; Lye DC
Int J Antimicrob Agents; 2007 Oct; 30(4):356-9. PubMed ID: 17631986
[TBL] [Abstract][Full Text] [Related]
4. Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections.
Trad MA; Zhong LH; Llorin RM; Tan SY; Chan M; Archuleta S; Sulaiman Z; Tam VH; Lye DC; Fisher DA
J Chemother; 2017 Feb; 29(1):25-29. PubMed ID: 27239695
[TBL] [Abstract][Full Text] [Related]
5. Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Cho SY; Choi SM; Park SH; Lee DG; Choi JH; Yoo JH
Korean J Intern Med; 2016 Jan; 31(1):156-61. PubMed ID: 26767869
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study.
Esteve-Palau E; Solande G; Sánchez F; Sorlí L; Montero M; Güerri R; Villar J; Grau S; Horcajada JP
J Infect; 2015 Dec; 71(6):667-74. PubMed ID: 26380898
[TBL] [Abstract][Full Text] [Related]
7. Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study.
Fink DL; Collins S; Barret R; Pollara G; Marks M; Logan S
PLoS One; 2019; 14(9):e0223130. PubMed ID: 31557236
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.
Tinelli M; Cataldo MA; Mantengoli E; Cadeddu C; Cunietti E; Luzzaro F; Rossolini GM; Tacconelli E
J Antimicrob Chemother; 2012 Dec; 67(12):2982-7. PubMed ID: 22865381
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report.
Berg ML; Crank CW; Philbrick AH; Hayden MK
Ann Pharmacother; 2008 Feb; 42(2):207-12. PubMed ID: 18230703
[TBL] [Abstract][Full Text] [Related]
11. Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children.
Hyun HS; Kim JH; Cho MH; Park E; Ha IS; Cheong HI; Kang HG
Pediatr Nephrol; 2019 Nov; 34(11):2399-2407. PubMed ID: 31270617
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Cost Comparison of Ertapenem as Outpatient Parenteral Antimicrobial Therapy in Acute Pyelonephritis due to Extended-spectrum Beta-lactamase-producing
Ramasubramanian V; Murlidharan P; Nambi S; Pavithra S; Puthran S; Petigara T
Indian J Nephrol; 2018; 28(5):351-357. PubMed ID: 30270995
[TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre.
Jacmel L; Timsit S; Ferroni A; Auregan C; Angoulvant F; Chéron G
Acta Paediatr; 2017 Jan; 106(1):142-147. PubMed ID: 27542840
[TBL] [Abstract][Full Text] [Related]
14. [Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
Forestier E; Gros S; Peynaud D; Levast M; Boisseau D; Ferry-Blanco C; Labe A; Lecomte C; Rogeaux O
Med Mal Infect; 2012 Sep; 42(9):440-3. PubMed ID: 22925551
[TBL] [Abstract][Full Text] [Related]
15. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital.
Osthoff M; McGuinness SL; Wagen AZ; Eisen DP
Int J Infect Dis; 2015 May; 34():79-83. PubMed ID: 25769526
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy.
Bajpai T; Pandey M; Varma M; Bhatambare GS
Indian J Pathol Microbiol; 2014; 57(3):407-12. PubMed ID: 25118732
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
[TBL] [Abstract][Full Text] [Related]
19. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
[TBL] [Abstract][Full Text] [Related]
20. Urinary tract infections caused by extended-spectrum betalactamase-producing bacteria in children: a matched casecontrol study.
Dotis J; Printza N; Marneri A; Gidaris D; Papachristou F
Turk J Pediatr; 2013; 55(6):571-4. PubMed ID: 24577973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
